Future Farm Technologies Inc (OTCMKTS:FFRMF) Announces Completion of Cultivation and Extraction Operation in …
Future Farm Technologies Inc (OTCMKTS:FFRMF) has successfully completed the Attleboro, Massachusetts based cultivation and extraction operation. The company has procured bids from the contractors to enter the next phase of development.
It has also demolished the interior of the Providence, Rhode Island building. The company will use this space for building a cultivation facility. The MI-zone based building is legally allowed for the cultivation of cannabis.
The licensed cultivators can lease this space from Future Farm Technologies to cultivate medical marijuana and supply to the state sanctioned dispensaries in Rhode Island. The company has already received an LOI from the provisionally licensed cultivator to take the property on lease. Negotiations for the lease of this space is currently progressing.
The Rhode Island Lessee and Future Farm Technologies will benefit from close proximity and put in considerable efforts to improve efficiencies and get better pricing from the suppliers and vendors. Derek Ross, Chief Project Manager has accepted the bids submitted by the four general contractors, who are keen to work on high profile projects.
Future Farm Technologies Is All Set to Utilize Underserved Areas in Southeastern Massachusetts
Mr. Ross said Rhode Island and Southeastern Massachusetts are not utilized in New England cannabis ecosystem. The company will play a vital role in utilizing these areas and meet the growing demand for adult use of cannabis.
Future Farm Technologies Issues An Update on Cannabis Breeding and in-vitro propagation business segment
Future Farm Technologies has announced that in-vitro propagation business and cannabis breeding segment is selecting top-notch professionals to conduct the research in its St. John’s, Newfoundland based laboratory. This new move will be concluded in November 2018.
The main aim of the Joint Venture is to position Future Farm Technologies in a leadership role in the R&D of biochemistry, genetics